NVIDIA BioNeMo Toolkit Accelerates AI-Driven Drug Discovery
The post NVIDIA BioNeMo Toolkit Accelerates AI-Driven Drug Discovery appeared on BitcoinEthereumNews.com. Terrill Dicki Jul 10, 2026 13:41 NVIDIA’s BioNeMo Agent Toolkit boosts AI-powered co-folding, enabling faster drug discovery and large-scale protein modeling. NVIDIA’s BioNeMo Agent Toolkit, announced at the BIO conference in June 2026, is revolutionizing biomolecular structure prediction and drug discovery workflows with a suite of AI-accelerated tools. The toolkit integrates cutting-edge GPU optimizations to vastly improve the speed and scalability of co-folding processes, which are critical for understanding complex protein structures and predicting drug-target interactions. Co-folding models like OpenFold3 and RosettaFold3 have long been powerful tools in the life sciences, but their computational demands—especially for large molecular assemblies—have limited broader application. NVIDIA’s enhancements address these bottlenecks head-on, offering up to 177x fast